Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Unoprostone
Drug ID BADD_D02316
Description Unoprostone isopropyl is a prostaglandin analogue. Ophthalmic Solution 0.15% is a synthetic docosanoid. Unoprostone isopropyl has the chemical name isopropyl (+)-(Z)-7-[(1R,2R,3R,5S)-3,5 dihydroxy-2-(3-oxodecyl)cyclopentyl]-5-heptenoate. The main indication of Unoprostane is treatment of glucoma.
Indications and Usage For the lowering of intraocular pressure in patients with open-angle glaucoma or ocular hypertension who are intolerant of other intraocular pressure lowering medications or insufficiently responsive (failed to achieve target IOP determined after multiple measurements over time) to another intraocular pressure lowering medication.
Marketing Status approved; investigational
ATC Code S01EE02
DrugBank ID DB06826
KEGG ID D08661
MeSH ID C072630
PubChem ID 5311236
TTD Drug ID Not Available
NDC Product Code Not Available
UNII 6X4F561V3W
Synonyms isopropyl unoprostone | unoprostone isopropyl | isopropyl Z-7-((1R,2R,3R,5S)-3,5-dihydroxy-2-(3-oxodecyl)cyclopentyl)hept-5-enoate, D- | isopropyl 20-ethyl-9alpha,11alpha-dihydroxy-15-keto-cis-delta-5-prostanoate | Rescula | Eescula | UF 021 | UF-021
Chemical Information
Molecular Formula C22H38O5
CAS Registry Number 120373-36-6
SMILES CCCCCCCC(=O)CCC1C(CC(C1CC=CCCCC(=O)O)O)O
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Back pain15.03.04.005--
Blepharitis23.03.04.012; 06.04.04.001--Not Available
Bronchitis22.07.01.001; 11.01.09.001--
Cataract06.06.01.001--
Colour blindness06.02.09.001; 03.01.01.001--Not Available
Conjunctival oedema06.04.01.001--Not Available
Conjunctivitis11.01.06.012; 06.04.01.002--
Corneal deposits06.06.03.002--Not Available
Corneal erosion06.06.03.003--Not Available
Corneal lesion06.06.03.004--Not Available
Corneal oedema06.04.02.001--Not Available
Corneal opacity06.06.03.005--Not Available
Cough22.02.03.001--
Diabetes mellitus14.06.01.001; 05.06.01.001--Not Available
Diplopia17.17.01.005; 06.02.06.002--Not Available
Dizziness02.11.04.006; 24.06.02.007; 17.02.05.003--
Dry eye06.08.02.001--
Dry mouth07.06.01.002--
Eye haemorrhage12.02.02.012; 24.07.05.002; 06.07.02.001--Not Available
Eye pain06.08.03.002--
Headache17.14.01.001--
Hypersensitivity10.01.03.003--
Hypertension24.08.02.001--
Injury12.01.08.004--Not Available
Insomnia19.02.01.002; 17.15.03.002--
Iritis10.02.01.022; 06.04.03.002--Not Available
Keratitis06.04.02.002--
Nausea07.01.07.001--
Optic atrophy06.09.02.001--Not Available
Pain08.01.08.004--
The 1th Page    1 2    Next   Last    Total 2 Pages